Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury [NA]
This clinical trial compares terlipressin to somatostatin in cirrhotic patients with acute gastrointestinal bleeding and acute kidney injury…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Molecular Mechanism of Exercise in Cirrhosis [NA]
A clinical trial in early stages is investigating how exercise influences molecular mechanisms in liver cirrhosis and is currently recruitin…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Erlotinib for Hepatocellular Carcinoma Chemoprevention [Phase 2]
Phase 2 clinical trial evaluating erlotinib for chemoprevention of hepatocellular carcinoma in patients with cirrhosis or advanced liver fib…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices [Phase 4]
Phase 4 trial comparing 24-hour versus 72-hour octreotide infusion to prevent early rebleeding from esophageal varices in patients with live…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Comparative Study of Novel Prognostic Scores in Patients With Liver Cirrhosis
This clinical trial update describes a planned comparative study evaluating novel prognostic scores in patients with liver cirrhosis, with t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Fibroscan Study in HCC [NA]
The document provides an update on a Fibroscan study in hepatocellular carcinoma, including patients scheduled for transarterial chemoemboli…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial [Phase 1]
Phase 1 clinical trial MARCO (Microbiota Augmentation to Reestablish Commensal Organisms) investigating a microbiota-based therapy for liver…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Developing Viability Index for Machine Perfused Livers [NA]
The document notes a clinical trial from Massachusetts General Hospital to develop a viability index for machine-perfused livers. The study …
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV [Phase 2]
Phase 2 results assess the safety and efficacy of Bemnifosbuvir and Ruzasvir in adults with chronic hepatitis C, including patients with liv…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
This clinical trial update discusses indications for liver transplantation in patients with cirrhosis and severe acute-on-chronic liver fail…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: FAST (Focused Abbreviated Screening Technique)-MRI Study
The FAST-MRI study, sponsored by Icahn School of Medicine at Mount Sinai, is currently enrolling by invitation and focuses on patients with …
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients [NA]
A clinical trial is evaluating laparoscopic partial splenectomy to treat hypersplenism in patients with liver cirrhosis. The study is curren…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
A completed clinical trial sponsored by Assiut University evaluating short-term outcomes in hospitalized patients with liver cirrhosis.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Clinical trial evaluating the utility of [68Ga]Ga-PSMA-11 PET/MRI for assessing liver cirrhosis and related conditions is currently recruiti…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Liver Cirrhosis Patients' Digital Health Literacy and Perspective on Digital Healthcare, a Multicenter Questionnaire Study [NA]
A completed multicenter questionnaire study evaluating digital health literacy and perspectives on digital healthcare among patients with li…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study
This clinical trial update describes a multicenter retrospective cohort study evaluating healthcare utilization in patients with liver cirrh…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Evaluation of Remote Monitoring of Liver Cirrhosis Patients
This Clinical Trial Update describes a study evaluating remote monitoring for patients with liver cirrhosis. The trial is not yet recruiting…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: VICIS - Vienna Cirrhosis Study
This is an update on the VICIS Vienna Cirrhosis Study. The multicenter trial led by the Medical University of Vienna is currently recruiting…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
A clinical trial update describing a study on proteomic and microbiome changes in patients with hepatic encephalopathy, sponsored by The Fir…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC [NA]
This clinical trial update describes the real-world implementation and validation of the Elecsys GAAD assay to improve surveillance and earl…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk [Phase 2]
Phase 2 clinical trial evaluating whether atorvastatin reduces hepatocellular carcinoma risk compared with placebo in patients with liver fi…
-
CLINICAL_TRIALS other · 2025-09-19Clinical Trial Update: Liver Disease and Other Systemic Diseases
A recruiting clinical trial sponsored by Taipei Tzu Chi Hospital and Buddhist Tzu Chi Medical Foundation is studying liver diseases and rela…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)
The IMPHROVE-D trial reports improvement of portal hypertension in patients with hepatitis D during viral suppression; the study is active b…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prehabilitation and Posttransplant Training Program in Liver Transplantation [NA]
This clinical trial update describes a prehabilitation and posttransplant training program for patients undergoing liver transplantation, cu…
-
FDA approval · 2025-09-12FDA Approved: ENBUMYST — Original Application (Corstasis USA LLC)
The FDA approves ENBUMYST (bumetanide) from Corstasis USA LLC via its Original Application (NDA219500).